Sr. Director at Pew Charitable Trusts, Allan Coukell, Discusses Opportunities for FDA Reform

MONDAY, FEBRUARY 13, 2017
This week, hosts Mark Masselli and Margaret Flinter speak with Allan Coukell, Sr. Director for Health Programs at the Pew Charitable Trusts, where he oversees the FDA, drug and medical device safety and the opioid crisis. He discusses suggested changes to the FDA made by the Trump Administration, and how best to promote reforms at the US Food and Drug Administration to better respond to 21st century advances in research and discovery.

To download audio file, click here.

Sr. Director at Pew Charitable Trusts, Allan Coukell, Discusses Opportunities for FDA Reform Image
More Like This
Guardrails for Health AI: How, Why and When Image
Guardrails for Health AI: How, Why and When
Do Your 2025 Healthcare Predictions Match Up With What an Expert Says?   Image
Do Your 2025 Healthcare Predictions Match Up With What an Expert Says?
Health Care & President Trump: What’s Happened So Far Image
Health Care & President Trump: What’s Happened So Far
NEJM’s 1st AI Editor on Tech’s Pluses & Minuses    Image
NEJM’s 1st AI Editor on Tech’s Pluses & Minuses